Simultaneous integrated boost using intensity-modulated radiotherapy compared with conventional radiotherapy in patients treated with concurrent carboplatin and 5-fluorouracil for locally advanced oropharyngeal carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 2, 2012, Pages 582-589

  Clavel, Sébastien ^a   Nguyen, David H A ^b   Fortin, Bernard ^b   Després, Philippe ^a   Khaouam, Nader ^b   Donath, David ^a   Soulires, Denis ^a   Guertin, Louis ^a   Nguyen Tan, Phuc Felix ^b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

Head and neck cancer; Intensity modulated radiotherapy chemoradiation; Oropharyngeal carcinoma

Indexed keywords

5-FLUOROURACIL; CARBOPLATIN; CHEMORADIATION; DISEASE FREE SURVIVAL; HEAD-AND-NECK CANCER; INTENSITY-MODULATED RADIOTHERAPY; KAPLAN-MEIER METHOD; LOCOREGIONAL CONTROL; MULTI VARIATE ANALYSIS; OROPHARYNGEAL; OROPHARYNGEAL CANCER; OVERALL SURVIVAL; SIMULTANEOUS INTEGRATED BOOSTS; SURVIVAL RATE; XEROSTOMIA;

CHEMOTHERAPY; DISEASE CONTROL; DISEASES; INTEGRATION; MULTIVARIANT ANALYSIS; PATIENT MONITORING; PHYSICAL THERAPY;

RADIOTHERAPY;

CARBOPLATIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CHEMORADIOTHERAPY; CONTINUOUS INFUSION; DERMATITIS; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NECK DISSECTION; OROPHARYNX CARCINOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION NECROSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; THERAPY EFFECT; TINNITUS; TRISMUS; XEROSTOMIA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES;

EID: 84855826826     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.10.061     Document Type: Article

References (27)

1. J.P. Pignon, J. Bourhis, and C. Domenge Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer Lancet 355 2000 949 955
2. G. Calais, M. Alfonsi, and E. Bardet Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma J Natl Cancer Inst 91 1999 2081 2086
3. D.J. Adelstein, Y. Li, and G.L. Adams An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer J Clin Oncol 21 2003 92 98
4. W.M. Mendenhall, R.J. Amdur, and J.R. Palta Intensity-modulated radiotherapy in the standard management of head and neck cancer: Promises and pitfalls J Clin Oncol 24 2006 2618 2623
5. H.B. Caglar, and A.M. Allen Intensity-modulated radiotherapy for head and neck cancer Clin Adv Hematol Oncol 5 2007 425 431
6. A. Eisbruch Radiotherapy: IMRT reduces xerostomia and potentially improves QoL Nat Rev Clin Oncol 6 2009 567 568
7. H.D. Pacholke, R.J. Amdur, and C.G. Morris Late xerostomia after intensity-modulated radiation therapy versus conventional radiotherapy Am J Clin Oncol 28 2005 351 358
8. N.Y. Lee, F.F. de Arruda, and D.R. Puri A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma Int J Radiat Oncol Biol Phys 66 2006 966 974
9. S. Jabbari, H.M. Kim, and M. Feng Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: Initial report Int J Radiat Oncol Biol Phys 63 2005 725 731
10. M.R. Vergeer, P.A. Doornaert, and D.H. Rietveld Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: Results of a nonrandomized prospective study using a standardized follow-up program Int J Radiat Oncol Biol Phys 74 2009 1 8
11. S.E. Mowry, C. Tang, and A. Sadeghi Standard chemoradiation versus intensity-modulated chemoradiation: A quality of life assessment in oropharyngeal cancer patients Eur Arch Otorhinolaryngol 267 2010 1111 1116
12. A. Lin, H.M. Kim, and J.E. Terrell Quality of life after parotid-sparing IMRT for head-and-neck cancer: A prospective longitudinal study Int J Radiat Oncol Biol Phys 57 2003 61 70
13. F.F. de Arruda, D.R. Puri, and J. Zhung Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: The Memorial Sloan-Kettering Cancer Center experience Int J Radiat Oncol Biol Phys 64 2006 363 373
14. K.S. Chao, N. Majhail, and C.J. Huang Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: A comparison with conventional techniques Radiother Oncol 61 2001 275 280
15. K.E. Rusthoven, D. Raben, and A. Ballonoff Effect of radiation techniques in treatment of oropharynx cancer Laryngoscope 118 2008 635 639
16. G.O. Schoenfeld, R.J. Amdur, and C.G. Morris Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer Int J Radiat Oncol Biol Phys 71 2008 377 385
17. F.L. Greene, C.M. Balch, and D.L. Page AJCC cancer staging manual 6th ed. 2002 Springer New York
18. A. Trotti, A. Colevas, and A. Setser CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment Vol 13 2003 Elsevier New York p. 176-181
19. Clavel S, Fortin B, Despres P, et al. Enteral feeding during chemoradiotherapy for advanced head-and-neck cancer: A single-institution experience using a reactive approach. Int J Radiat Oncol Biol Phys. 2010. May 4th (Epub ahead of print).
20. J. Bourhis, J. Overgaard, and H. Audry Hyperfractionated or accelerated radiotherapy in head and neck cancer: A meta-analysis Lancet 368 2006 843 854
21. K.K. Fu, T.F. Pajak, and A. Trotti A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003 Int J Radiat Oncol Biol Phys 48 2000 7 16
22. E. Orlandi, M. Palazzi, and E. Pignoli Radiobiological basis and clinical results of the simultaneous integrated boost (SIB) in intensity modulated radiotherapy (IMRT) for head and neck cancer: A review Crit Rev Oncol Hematol 73 2010 111 125
23. M. Yao, K.J. Dornfeld, and J.M. Buatti Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma - the University of Iowa experience Int J Radiat Oncol Biol Phys 63 2005 410 421
24. C.W. Hodge, S.M. Bentzen, and G. Wong Are we influencing outcome in oropharynx cancer with intensity-modulated radiotherapy? An inter-era comparison Int J Radiat Oncol Biol Phys 69 2007 1032 1041
25. M.J. Been, J. Watkins, and R.M. Manz Tumor volume as a prognostic factor in oropharyngeal squamous cell carcinoma treated with primary radiotherapy Laryngoscope 118 2008 1377 1382
26. J.D. Ruben, S. Davis, and C. Evans The effect of intensity-modulated radiotherapy on radiation-induced second malignancies Int J Radiat Oncol Biol Phys 70 2008 1530 1536
27. M.W. Munter, S. Hoffner, and H. Hof Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: Comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without Amifostine Int J Radiat Oncol Biol Phys 67 2007 651 659